BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31691433)

  • 1. Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.
    Zheng P; Chen X; Xie J; Chen X; Lin S; Ye L; Chen L; Lin J; Yu X; Zheng M
    Cancer Sci; 2020 Jan; 111(1):72-83. PubMed ID: 31691433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
    Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
    Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
    Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
    J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
    Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
    Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression.
    Zheng PC; Chen X; Zhu HW; Zheng W; Mao LH; Lin C; Liu JN; Zheng M
    Cancer Sci; 2014 Jun; 105(6):630-8. PubMed ID: 24703594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
    Chang PY; Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
    Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV‑LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.
    Xu S; Bai J; Zhuan Z; Li B; Zhang Z; Wu X; Luo X; Yang L
    Oncol Rep; 2018 Jul; 40(1):377-384. PubMed ID: 29749553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.
    Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH
    Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
    Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
    Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.